Graham D. Sher

Clinical Outcomes Following Institution of the Canadian Universal Leukoreduction Program for Red Blood Cell Transfusions

Paul C. Hébert, Dean Fergusson, Morris A. Blajchman et al. · JAMA · 2003 · 391 citations

A randomized controlled trial comparing the frequency of acute reactions to plasma‐removed platelets and prestorage WBC‐reduced platelets

Nancy M. Heddle, Morris A. Blajchman, Ralph M. Meyer et al. · Transfusion · 2002 · 207 citations

Extended Therapy with Intravenous Arginine Butyrate in Patients with β-Hemoglobinopathies

Graham D. Sher, Gordon D. Ginder, Jane A. Little et al. · New England Journal of Medicine · 1995 · 172 citations · Full text

A multivariable model for predicting the need for blood transfusion in patients undergoing first‐time elective coronary bypass graft surgery

Keyvan Karkouti, Marsha M. Cohen, Stuart A. McCluskey et al. · Transfusion · 2001 · 139 citations

Incidence and estimated rates of residual risk for HIV, hepatitis C, hepatitis B and human T-cell lymphotropic viruses in blood donors in Canada, 1990-2000.

Jo Anne Chiavetta, Michael Escobar, Alice Newman et al. · PubMed · 2003 · 127 citations

Viral Hepatitis, Human Retrovirus, Clinical Epidemiology +18